Consumer Goods & Retail Global On demand · 24-48h

Global Cosmetics Anti-inflammatory Ingredient Market Strategic Research Report

Name: Global Cosmetics Anti-inflammatory Ingredient Market Strategic Research Report
Brand: Market Research Reports, Inc.
Price: 3500 USD
Availability: PreOrder

Global Cosmetics Anti-inflammatory Ingredient Market Strateg…

$3,500 USD

Strategic Research Report

Global Cosmetics Anti-inflammatory Ingredient Market

Market Research Reports · Global

Market Research Reports Intelligence Series

By Type: Purslane Extract, Centella Asiatica Extract, Nicotinamide, Allantoin, Peptide, Bisabolol, Resveratrol, Others

By Application: Facial Care, Body Care, Hand Care, Foot Care, Others

Key Players: Lonza, Jubilant Life Sciences, Vertellus, Lasons India, DSM, BASF, Indena S.p.A., Symrise, Croda, Seppic, Lipoid Kosmetik AG, Plamed Green Science Group, Durae Corporation, Dermalab, The Garden of Naturalsolution, Ashland, Akema, Clariant, Rita Corp, ExperChem, Active Peptide Company, Evolva, Sabinsa, InterHealth, Maypro, Laurus Labs

Region: Global

Formats: PDF, Excel, Word & PowerPoint

Base year: 2024 · forecast to 2032

Length: 178 pages

Vue d'ensemble

Scope of the Report

Global key Cosmetics Anti-inflammatory Ingredient players cover Lonza, Jubilant Life Sciences, Vertellus, Lasons India, DSM, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Cosmetics Anti-inflammatory Ingredient market?

What factors are driving Cosmetics Anti-inflammatory Ingredient market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Cosmetics Anti-inflammatory Ingredient market opportunities vary by end market size?

How does Cosmetics Anti-inflammatory Ingredient break out by Type, by Application?

This report presents a comprehensive overview of the global Cosmetics Anti-inflammatory Ingredient market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

Purslane Extract
Centella Asiatica Extract
Nicotinamide
Allantoin
Peptide
Bisabolol
Resveratrol
Others

Segment by Application

Facial Care
Body Care
Hand Care
Foot Care
Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Cosmetics Anti-inflammatory Ingredient market:

Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
Distributors, channel partners and end users in Facial Care, Body Care, Hand Care evaluating demand and sourcing options
Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
Government agencies, industry associations and research institutions tracking industry developments and policy impact

Segments covered in this report

By Type

Purslane ExtractCentella Asiatica ExtractNicotinamideAllantoinPeptideBisabololResveratrolOthers

By Application

Facial CareBody CareHand CareFoot CareOthers

Click a chapter to expand

01Executive Summary

02Industry Overview & Forecast

2.1.1 Market Definition and Scope
2.1.2 Market Size and Growth Forecast
2.1.3 Volume Analysis
2.1.4 Segment Outlook by Type
2.1.5 Segment Outlook by Application
2.1.6 Regional Outlook
2.1.7 Structural Developments Shaping the Forecast
2.1.8 Forecast Risks and Sensitivities

03Market Segmentation by Type

3.1 Market Segmentation by Type
3.1.1 Market by Type Overview
3.1.2 Purslane Extract
3.1.3 Centella Asiatica Extract
3.1.4 Nicotinamide
3.1.5 Allantoin
3.1.6 Peptide
3.1.7 Bisabolol
3.1.8 Resveratrol
3.1.9 Others
3.1.10 Volume Analysis

04Market Segmentation by Application

4.1 Market Segmentation by Application
4.1.1 Market by Application Overview
4.1.2 Facial Care
4.1.3 Body Care
4.1.4 Hand Care
4.1.5 Foot Care
4.1.6 Others
4.1.7 Volume Analysis

05Regional Market Forecast

Asia Pacific
North America
Europe
Middle East & Africa
Latin America

06Country-Level Market Forecast

6.1 Asia Pacific
6.1.1 China
6.1.2 Japan
6.1.3 Korea
6.1.4 Southeast Asia
6.1.5 India
6.1.6 Australia
6.1.7 Rest of Asia Pacific
6.2 North America
6.2.1 United States
6.2.2 Canada
6.2.3 Mexico
6.2.4 Rest of North America
6.3 Europe
6.3.1 Germany
6.3.2 France
6.3.3 UK
6.3.4 Italy
6.3.5 Russia
6.3.6 Rest of Europe
6.4 Middle East & Africa
6.4.1 Egypt
6.4.2 South Africa
6.4.3 Israel
6.4.4 Turkey
6.4.5 GCC Countries
6.4.6 Rest of Middle East & Africa
6.5 Latin America
6.5.1 Brazil
6.5.2 Rest of Latin America

07Growth Drivers & Inhibitors

7.1 Growth Drivers & Inhibitors
7.1.1 Section Overview
7.1.2 Growth Drivers
7.1.3 Growth Inhibitors
7.1.4 Driver and Inhibitor Impact Assessment
7.1.5 Analyst Perspective

08Key Company Profiles

8.1 Lonza
8.1.1 Company Overview
8.1.2 Key Products & Segments
8.1.3 Financial Performance (2023–2025)
8.1.4 Business Strategy
8.1.5 SWOT Analysis
8.1.6 Strategic Implications (2026–2032)
8.2 Jubilant Life Sciences
8.2.1 Company Overview
8.2.2 Key Products & Segments
8.2.3 Financial Performance (2023–2025)
8.2.4 Business Strategy
8.2.5 SWOT Analysis
8.2.6 Strategic Implications (2026–2032)
8.3 Vertellus
8.3.1 Company Overview
8.3.2 Key Products & Segments
8.3.3 Financial Performance (2023–2025)
8.3.4 Business Strategy
8.3.5 SWOT Analysis
8.3.6 Strategic Implications (2026–2032)
8.4 Lasons India
8.4.1 Company Overview
8.4.2 Key Products & Segments
8.4.3 Financial Performance (2023–2025)
8.4.4 Business Strategy
8.4.5 SWOT Analysis
8.4.6 Strategic Implications (2026–2032)
8.5 DSM
8.5.1 Company Overview
8.5.2 Key Products & Segments
8.5.3 Financial Performance (2023–2025)
8.5.4 Business Strategy
8.5.5 SWOT Analysis
8.5.6 Strategic Implications (2026–2032)
8.6 BASF
8.6.1 Company Overview
8.6.2 Key Products & Segments
8.6.3 Financial Performance (2023–2025)
8.6.4 Business Strategy
8.6.5 SWOT Analysis
8.6.6 Strategic Implications (2026–2032)
8.7 Indena S.p.A.
8.7.1 Company Overview
8.7.2 Key Products & Segments
8.7.3 Financial Performance (2023–2025)
8.7.4 Business Strategy
8.7.5 SWOT Analysis
8.7.6 Strategic Implications (2026–2032)
8.8 Symrise
8.8.1 Company Overview
8.8.2 Key Products & Segments
8.8.3 Financial Performance (2023–2025)
8.8.4 Business Strategy
8.8.5 SWOT Analysis
8.8.6 Strategic Implications (2026–2032)
8.9 Croda
8.9.1 Company Overview
8.9.2 Key Products & Segments
8.9.3 Financial Performance (2023–2025)
8.9.4 Business Strategy
8.9.5 SWOT Analysis
8.9.6 Strategic Implications (2026–2032)
8.10 Seppic
8.10.1 Company Overview
8.10.2 Key Products & Segments
8.10.3 Financial Performance (2023–2025)
8.10.4 Business Strategy
8.10.5 SWOT Analysis
8.10.6 Strategic Implications (2026–2032)
8.11 Lipoid Kosmetik AG
8.11.1 Company Overview
8.11.2 Key Products & Segments
8.11.3 Financial Performance (2023–2025)
8.11.4 Business Strategy
8.11.5 SWOT Analysis
8.11.6 Strategic Implications (2026–2032)
8.12 Plamed Green Science Group
8.12.1 Company Overview
8.12.2 Key Products & Segments
8.12.3 Financial Performance (2023–2025)
8.12.4 Business Strategy
8.12.5 SWOT Analysis
8.12.6 Strategic Implications (2026–2032)
8.13 Durae Corporation
8.13.1 Company Overview
8.13.2 Key Products & Segments
8.13.3 Financial Performance (2023–2025)
8.13.4 Business Strategy
8.13.5 SWOT Analysis
8.13.6 Strategic Implications (2026–2032)
8.14 Dermalab
8.14.1 Company Overview
8.14.2 Key Products & Segments
8.14.3 Financial Performance (2023–2025)
8.14.4 Business Strategy
8.14.5 SWOT Analysis
8.14.6 Strategic Implications (2026–2032)
8.15 The Garden of Naturalsolution
8.15.1 Company Overview
8.15.2 Key Products & Segments
8.15.3 Financial Performance (2023–2025)
8.15.4 Business Strategy
8.15.5 SWOT Analysis
8.15.6 Strategic Implications (2026–2032)
8.16 Ashland
8.16.1 Company Overview
8.16.2 Key Products & Segments
8.16.3 Financial Performance (2023–2025)
8.16.4 Business Strategy
8.16.5 SWOT Analysis
8.16.6 Strategic Implications (2026–2032)
8.17 Akema
8.17.1 Company Overview
8.17.2 Key Products & Segments
8.17.3 Financial Performance (2023–2025)
8.17.4 Business Strategy
8.17.5 SWOT Analysis
8.17.6 Strategic Implications (2026–2032)
8.18 Clariant
8.18.1 Company Overview
8.18.2 Key Products & Segments
8.18.3 Financial Performance (2023–2025)
8.18.4 Business Strategy
8.18.5 SWOT Analysis
8.18.6 Strategic Implications (2026–2032)
8.19 Rita Corp
8.19.1 Company Overview
8.19.2 Key Products & Segments
8.19.3 Financial Performance (2023–2025)
8.19.4 Business Strategy
8.19.5 SWOT Analysis
8.19.6 Strategic Implications (2026–2032)
8.20 ExperChem
8.20.1 Company Overview
8.20.2 Key Products & Segments
8.20.3 Financial Performance (2023–2025)
8.20.4 Business Strategy
8.20.5 SWOT Analysis
8.20.6 Strategic Implications (2026–2032)
8.21 Active Peptide Company
8.21.1 Company Overview
8.21.2 Key Products & Segments
8.21.3 Financial Performance (2023–2025)
8.21.4 Business Strategy
8.21.5 SWOT Analysis
8.21.6 Strategic Implications (2026–2032)
8.22 Evolva
8.22.1 Company Overview
8.22.2 Key Products & Segments
8.22.3 Financial Performance (2023–2025)
8.22.4 Business Strategy
8.22.5 SWOT Analysis
8.22.6 Strategic Implications (2026–2032)
8.23 Sabinsa
8.23.1 Company Overview
8.23.2 Key Products & Segments
8.23.3 Financial Performance (2023–2025)
8.23.4 Business Strategy
8.23.5 SWOT Analysis
8.23.6 Strategic Implications (2026–2032)
8.24 InterHealth
8.24.1 Company Overview
8.24.2 Key Products & Segments
8.24.3 Financial Performance (2023–2025)
8.24.4 Business Strategy
8.24.5 SWOT Analysis
8.24.6 Strategic Implications (2026–2032)
8.25 Maypro
8.25.1 Company Overview
8.25.2 Key Products & Segments
8.25.3 Financial Performance (2023–2025)
8.25.4 Business Strategy
8.25.5 SWOT Analysis
8.25.6 Strategic Implications (2026–2032)
8.26 Laurus Labs
8.26.1 Company Overview
8.26.2 Key Products & Segments
8.26.3 Financial Performance (2023–2025)
8.26.4 Business Strategy
8.26.5 SWOT Analysis
8.26.6 Strategic Implications (2026–2032)

09Competitive Landscape

9.1 Competitive Landscape Overview
9.2 Competitive Intensity Assessment
9.3 Key Player Strategies & Positioning
9.4 Competitive Dynamics & Strategic Outlook
9.4.1 Emerging Competitive Threats
9.4.2 Consolidation vs. Fragmentation Outlook
9.4.3 Competitive Response Matrix
9.4.4 Strategic Recommendations, 2026–2032

10Porter's Five Forces Analysis

10.1 Threat of New Entrants
10.2 Bargaining Power of Buyers
10.3 Bargaining Power of Suppliers
10.4 Threat of Substitutes
10.5 Competitive Rivalry

11PESTLE Analysis

11.1 Political
11.2 Economic
11.3 Social and Demographic
11.4 Technological
11.5 Legal and Regulatory
11.6 Environmental
11.7 Strategic Implications of the PESTLE Assessment

12SWOT Analysis

13Future Trends & Outlook

13.1 Future Trends & Outlook
13.1.1 Trend Summary and Commercial Maturity Assessment
13.1.2 Technology and Innovation Trends
13.1.3 Long-Term Market Outlook
13.1.4 Investment & M&A Activity Outlook
13.1.5 Overall Outlook Assessment

Frequently asked questions

How is Cosmetics Anti-inflammatory Ingredient defined?

Global key Cosmetics Anti-inflammatory Ingredient players cover Lonza, Jubilant Life Sciences, Vertellus, Lasons India, DSM, etc.

How is the Cosmetics Anti-inflammatory Ingredient market segmented by type?

By type, the market is segmented into Purslane Extract, Centella Asiatica Extract, Nicotinamide, Allantoin, Peptide, Bisabolol, Resveratrol and Others.

What are the key applications of Cosmetics Anti-inflammatory Ingredient?

Key applications covered include Facial Care, Body Care, Hand Care, Foot Care and Others.

Which companies are profiled in the Cosmetics Anti-inflammatory Ingredient market report?

Key players profiled include Lonza, Jubilant Life Sciences, Vertellus, Lasons India, DSM, BASF, Indena S.p.A. and Symrise, among 26 companies covered in total.

What geographies does the Cosmetics Anti-inflammatory Ingredient market analysis include?

The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.

What are the key demand drivers for Cosmetics Anti-inflammatory Ingredient?

What factors are driving Cosmetics Anti-inflammatory Ingredient market growth, globally and by region?

Who should buy the Cosmetics Anti-inflammatory Ingredient market report?

The report is intended for manufacturers and solution providers, distributors and end users in Facial Care, Body Care and Hand Care, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Cosmetics Anti-inflammatory Ingredient market.

What license options are available for this report?

The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.